Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.71 USD | -1.78% | -0.91% | -10.94% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.94% | 1.66B | |
+24.17% | 562B | |
-6.42% | 358B | |
+19.02% | 322B | |
+7.62% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.53% | 149B | |
-6.85% | 146B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Says Patient Enrollment in Late-Stage Idiopathic Hypersomnia Trial Ahead of Schedule; Shares Up